<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02791997</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL14_0202</org_study_id>
    <nct_id>NCT02791997</nct_id>
  </id_info>
  <brief_title>Audition After a Lesion and in Migraine. (AuditionPostLesion)</brief_title>
  <official_title>Consequences of a Brain Lesion or of Migraine on Auditory Processing: Attention, Memory and Emotion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project studies auditory processing after brain damage (in temporal and/or frontal areas)
      and in migraine. The auditory processes investigated are attention, short-term memory,
      sound-induced emotions. To characterize auditory deficits after brain damage or in migraine,
      neuropsychological assessments are combined with neurophysiological markers
      (Electro-encephalography: EEG, Magneto-encephalography: MEG, Magnetic Resonance Imaging:
      MRI).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2015</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentages of correct responses in Neuropsychological tests</measure>
    <time_frame>up to 2 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>reaction times in Neuropsychological tests</measure>
    <time_frame>up to 2 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Event-Related Potentials (EEG) in Neurophysiological tests</measure>
    <time_frame>up to 2 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Event-Related Fields (MEG) in Neurophysiological tests</measure>
    <time_frame>up to 2 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">335</enrollment>
  <condition>Migraine Disorders, Brain</condition>
  <arm_group>
    <arm_group_label>Brain-damaged patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control participants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Migraine patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neuropsychological tests</intervention_name>
    <description>Neuropsychological tests consist in listening to sounds in various contexts and providing behavioral responses with response-buttons.</description>
    <arm_group_label>Brain-damaged patients</arm_group_label>
    <arm_group_label>Control participants</arm_group_label>
    <arm_group_label>Migraine patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neurophysiological tests</intervention_name>
    <description>Neurophysiological tests consist in the recording of EEG and/or MEG signals while realizing the neuropsychological tests, as well as MRI scanning to characterize the patients' brain lesions and reconstruct the brain sources of surface EEG/MEG signals.</description>
    <arm_group_label>Brain-damaged patients</arm_group_label>
    <arm_group_label>Control participants</arm_group_label>
    <arm_group_label>Migraine patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age from 18 to 80

          -  MEG/MRI compatibility

          -  Motivation to participate efficiently in the study

          -  No severe hearing loss

          -  Informed consent to participate in the study

          -  Affiliation to social security

          -  For brain-damaged patients : no need for medical assistance; focal temporal and/or
             frontal lesion; no major cognitive impairment; ability to understand and apply the
             instructions for neuropsychological testing; testing at least one-month after the
             event resulting in brain damage; absence of neurological and psychiatric disorders
             besides the lesion

          -  For migraine patients: no need for medical assistance; migraine diagnosis; no major
             cognitive impairment; ability to understand and apply the instructions for
             neuropsychological testing; absence of neurological and psychiatric disorders besides
             the migraine

          -  Healthy participants: absence of neurological and psychiatric disorders

        Exclusion Criteria:

          -  Age below 18 or above 80

          -  MRI scanning not possible: artificial cardiac pacemaker, insulin pump, metallic
             prosthesis, intra-cerebral clip, claustrophobia

          -  MEG acquisition not possible: large heads, neurostimulator, metal in the head or the
             body.

          -  Pregnant or breast-feeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Norbert NIGHOGHOSSIAN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unité 201, Hôpital Neurologique, Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Norbert NIGHOGHOSSIAN, MD</last_name>
    <phone>4 72 68 13 22</phone>
    <phone_ext>+33</phone_ext>
    <email>norbert.nighoghossian@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne CACLIN</last_name>
    <phone>472138904</phone>
    <phone_ext>+33</phone_ext>
    <email>anne.caclin@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Unité 201, Hôpital Neurologique</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert NIGHOGHOSSIAN, MD</last_name>
      <phone>04 72 68 13 22</phone>
      <phone_ext>+33</phone_ext>
      <email>norbert.nighoghossian@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Anne CACLIN, MD</last_name>
      <phone>472138904</phone>
      <phone_ext>+33</phone_ext>
      <email>anne.caclin@inserm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Norbert NIGHOGHOSSIAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yves Berthezène, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julien Jung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service Explorations Fonctionnelles Neurologiques, Hôpital de la Croix-Rousse</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Geneviève Demarquay, MD</last_name>
      <phone>4 72 07 24 48</phone>
      <phone_ext>+33</phone_ext>
      <email>genevieve.demarquay@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Anne CACLIN</last_name>
      <phone>472138904</phone>
      <phone_ext>+33</phone_ext>
      <email>anne.caclin@inserm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Geneviève Demarquay, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 27, 2016</study_first_submitted>
  <study_first_submitted_qc>June 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 7, 2016</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Audition</keyword>
  <keyword>Stroke</keyword>
  <keyword>Migraine</keyword>
  <keyword>Attention</keyword>
  <keyword>Short-term memory,</keyword>
  <keyword>Emotions</keyword>
  <keyword>EEG</keyword>
  <keyword>MEG</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

